Vanguard disaggregates holdings; GILD reporting shows 0 shares (Vanguard)

The Vanguard Group has filed an amended Schedule 13G/A for Gilead Sciences Inc (GILD), reporting zero beneficial ownership of common stock. This change is due to an internal realignment where Vanguard and certain subsidiaries will now report holdings separately, citing SEC Release No. 34-39538. The amendment clarifies a structural reporting change rather than a sale of GILD shares, with subsidiaries now filing their own separate schedules.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin